Current findings show that asprosin plays a crucial role in obesity; its plasma levels are elevated in obese humans and mice and are correlated with insulin resistance, type 1, and type 2 diabetes mellitus [92, 93]. This evidence concerns the gene FBN1 and obesity disorder.